Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-05-10
2011-05-10
Chernyshev, Olga N (Department: 1649)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387100, C530S387900, C424S130100, C424S133100, C424S134100, C424S159100, C435S007100
Reexamination Certificate
active
07939641
ABSTRACT:
Provided herein are hybrid polypeptides that specifically bind to a disease-associated isoform of a polypeptide involved in diseases of protein aggregation. The hybrid polypeptides can be used for diagnosis and treatment of such diseases. In a particular embodiment, a hybrid protein that specifically binds to the infectious form of a prion (PrPSc) is provided.
REFERENCES:
patent: 3843443 (1974-10-01), Fishman
patent: 4006117 (1977-02-01), Merrifield et al.
patent: 4244721 (1981-01-01), Gupta et al.
patent: 4507230 (1985-03-01), Tam et al.
patent: 4908405 (1990-03-01), Bayer et al.
patent: 4952496 (1990-08-01), Studier et al.
patent: 5231167 (1993-07-01), Zanetti et al.
patent: 5292814 (1994-03-01), Bayer et al.
patent: 5306812 (1994-04-01), Zanetti et al.
patent: 5389449 (1995-02-01), Afeyan et al.
patent: 5508386 (1996-04-01), Zanetti et al.
patent: 5583202 (1996-12-01), Zanetti
patent: 5639581 (1997-06-01), Iwasaki et al.
patent: 5652138 (1997-07-01), Burton et al.
patent: 5658762 (1997-08-01), Zanetti et al.
patent: 5693478 (1997-12-01), Vitek et al.
patent: 5750361 (1998-05-01), Prusiner et al.
patent: 5763740 (1998-06-01), Prusiner et al.
patent: 5773572 (1998-06-01), Fishleigh et al.
patent: 5792901 (1998-08-01), Prusiner et al.
patent: 5846533 (1998-12-01), Prusiner et al.
patent: 5891641 (1999-04-01), Prusiner et al.
patent: 5908969 (1999-06-01), Prusiner et al.
patent: 5962669 (1999-10-01), Prusiner et al.
patent: 6114175 (2000-09-01), Klunk et al.
patent: 6172043 (2001-01-01), Ingram et al.
patent: 6214565 (2001-04-01), Prusiner et al.
patent: 6290954 (2001-09-01), Prusiner et al.
patent: 6372214 (2002-04-01), Prusiner et al.
patent: 6376170 (2002-04-01), Burton et al.
patent: 6537548 (2003-03-01), Prusiner et al.
patent: 6562341 (2003-05-01), Prusiner et al.
patent: 6677125 (2004-01-01), Prusiner et al.
patent: 2001/0001061 (2001-05-01), Prusiner et al.
patent: 2001/0014455 (2001-08-01), Prusiner et al.
patent: 2002/0018674 (2002-02-01), Miyamura
patent: 2002/0087502 (2002-07-01), Nagy et al.
patent: 2003/0114360 (2003-06-01), Cashman et al.
patent: 0 613 007 (1994-02-01), None
patent: A-7-501798 (2007-02-01), None
patent: 8603840 (1986-07-01), None
patent: WO 93/11155 (1993-06-01), None
patent: 9710505 (1997-03-01), None
patent: 97/16728 (1997-05-01), None
patent: 97/38011 (1997-10-01), None
patent: 9745746 (1997-12-01), None
patent: 99/15651 (1999-04-01), None
patent: 0068382 (2000-11-01), None
patent: 00/75324 (2000-12-01), None
patent: 0078344 (2000-12-01), None
patent: 0187911 (2001-11-01), None
patent: 0210335 (2002-02-01), None
patent: 03/085086 (2003-10-01), None
Adams et al., “The c-myconcogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice”,Nature, 318:533-5538 (1985).
Aguzzi, “Blood simple prion diagnostics”,Nature Medicine, 7(3):289-290 (2001).
Alexander et al., “Expression of the c-mycOncogene under Control of an Immunoglobulin Enhancer in Eμ-mycTransgenic Mice”,Molecular and Cellular Biology, 7(4):1436-1444 (1987).
Arndt et al., “Helix-stabilized Fv (hsFv) Antibody Fragments: Substituting the Constant Domains of a Fab Fragment for a Heterodimeric Coiled-coil Domain”,J. Mol. Biol., 312:221-228 (2001).
Bajaj et al., “Ultra-Rare-Event Detection Performance of a Custom Scanning Cytometer on a Model Preparation of Fetal nRBCs”,Cytometry, 39:285-294 (2000).
Baldwin et al., “Cloning of the Luciferase Structural Genes fromVibrio harveyiand Expression of Bioluminescence inEscherichia coli”, Biochemistry, 23:3663-3667 (1984).
Barbas III and D.R. Burton, “Selection and evolution of high-affinity human anti-viral antibodies”,Trends in Biotechnology, 14:230-234 (1996).
Barbas III and J. Wagner, “Synthetic Human Antibodies: Selecting and Evolving Functional Proteins”,Methods: A Companion to Methods in Enzymology, 8:94-103 (1995).
Basler et al, “Scrapie and Cellular PrP Isoforms Are Encoded by the Same Chromosomal Gene”,Cell, 46:417-428 (1986).
Benoist et al., “In vivo sequence requirements of the SV40 early promoter region”,Nature, 290:304-310 (1981).
Berg et al., “Long-Chain Polystyrene-Grafted Polyethylene Film Matrix: A New Support for Solid-Phase Peptide Synthesis”,Berg, 111:8024-8026 (1989).
Birkett et al., “Scrapie strains maintain biological phenotypes on propagation in a cell line in culture”,EMBO Journal, 20(13):3351-3358 (2001).
Brinster et al., “Regulation of metallothionein-thymidine kinase fusion plasmids injected into mouse eggs”,Nature, 296:39-42 (1982).
Bruce et al., “Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent”,Nature, 389:498-501 (1997).
Bunin et al., “The combinatorial synthesis and chemical and biological evaluation of a 1,4-benzodiazepine library”,Proc. Natl. Acad. Sci. USA, 91:4708-4712 (1994).
Burton et al., “Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody”,Science, 266:1024-1027 (1994).
Butz et al., “Immunization and Affinity Purification of Antibodies Using Resin-Immobilized Lysine-Branched Synthetic Peptides”,Peptide Research, 7(1):20-23 (1994).
Caughey, “Interactions between prion protein isoforms: the kiss of death?”,TRENDS in Biochemical Sciences, 26(4):235-242 (2001).
Chandler, “Encephalopathy in Mice Produced by Inoculation with Scrapie Brain Material”,The Lancet, ?:1378-1379 (1961).
Chen et al., “Analogous Organic Synthesis of Small-Compound Libraries: Validatino of Combinatorial Chemistry in Small-Molecule Synthesis”,J. Am. Chem. Soc., 116:2661-2662 (1994).
Clarke et al., “Evidence for the Multiplication of Scrapie Agent in Cell Culture”,Nature, 225:100-101 (1970).
De Wet et al., “Firefly Luciferase Gene: Structure and Expression in Mammalian Cells”,Molecular and Cellular Biology, 7(2):725-737 (1987).
De Boer et al., “Thetacpromoter: A functional hybrid derived from thetrpandlacpromoters”,Proc. Natl. Acad. Sci. USA, 80:21-25 (1983).
Demart et al., “New Insight into Abnormal Prion Protein Using Monoclonal Antibodies”,Biochemical and Biophysical Research Communications, 265:652-657 (1999).
DeWitt et al., ““Diversomers”: An approach to nonpeptide, nonoligomeric chemical diversity”,Proc. Natl. Acad. Sci. USA, 90:6909-6913 (1993).
Eck et al., “The Structure of Tumor Necrosis Factor-α at 2.6 Å Resolution”,The Journal of Biological Chemistry, 264(29):17595-17605 (1989).
Engebrecht, J. and M. Silverman, “Identification of genes and gene products necessary for bacterial bioluminescence”,Proc. Natl. Acad. Sci. USA, 81:4154-4158 (1984).
Fischer et al., “Binding of disease-associated prion protein to plasminogen”,Nature, 408:479-483 (2000).
Gabriel et al., “Molecular cloning of a candidate chicken protein”,Proc. Natl. Acad. Sci. USA, 89:9097-9101 (1992).
Gardner et al., “The complete nucleotide sequence of an infectious clone of cauliflower mosaic virus by M13mp7 shotgun sequencing”,Nucleic Acids Research, 9(12):2871-2889 (1981).
Goldmann et al., “Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon”,Journal of General Virology, 72:201-204 (1991).
Goldmann et al., “Novel polymorphisms in the caprine PrP gene: a codon 142 mutation associated with scrapie incubation period”,Journal of General Virology, 77:2885-2891 (1996).
Goldmann et al., “Corrigendum”,Journal of Gneral Virology, 78(3):697 (1996).
Goldmann et al., “Two alleles of a neural protein gene linked to scrapie in sheep”,Proc. Natl. Acad. Sci. USA, 87:2476-2480 (1990).
Grosschedl et al., “Introduction of a μ Immunoglobulin Gene into the Mouse Germ Line: Specific Expression i
Burton Dennis R.
Moroncini Gianluca
Williamson R. Anthony
Chernyshev Olga N
McKenna Long & Aldridge LLP
Seidman Stephanie
The Scripps Research Institute
LandOfFree
Motif-grafted hybrid polypeptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Motif-grafted hybrid polypeptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Motif-grafted hybrid polypeptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2656160